Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
63.40    -1.00 (-1.55%)
Bid:
63.30
Ask:
63.50
Spread: 0.20 (0.316%)
Market Cap: £560.09m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Share Capital Reduction Effective

17 Dec 2019 16:50

RNS Number : 2246X
IP Group PLC
17 December 2019
 

 

 

IP Group plc

('IP Group' or 'the Group' or 'the Company')

Share Capital Reduction Effective

 

IP Group (LSE:IPO), the developer of intellectual property-based businesses, announces that further to its announcements of 8 November and 25 November 2019, the High Court of England and Wales sanctioned the Company's application for its Capital Reduction on 17 December 2019.

The order of the High Court confirming the Capital Reduction and the statement of capital approved by the High Court in connection therewith were registered by the Registrar of Companies on 17 December 2019, whereupon the Capital Reduction became effective.

The Company confirms that, following the Capital Reduction, the issued share capital of the Company comprises 1,059,144,595 ordinary shares of 2p each; there are no shares held in treasury. The total number of voting rights in the Company is therefore 1,059,144,595.

Terms used but not defined in this announcement are as defined in the Company's announcement of 8 November 2019.

 

For further information please contact:

IP Group plc +44 (0) 20 7444 0050

Alan Aubrey, Chief Executive Officer

Greg Smith, Chief Financial Officer

 

Liz Vaughan-Adams, Communications +44 (0) 20 7444 0062

+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson +44 (0) 7810 636995

David Gaffney +44 (0) 7854 609998

 

Notes for editors

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCQDLFFKLFZFBD
Date   Source Headline
15th Mar 20239:31 amRNSInvestor presentation
13th Mar 20239:00 amRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSNo direct deposits or credit facilities with SVB
8th Mar 20237:00 amRNSIP Group plc - Annual Results
2nd Mar 20233:25 pmRNSTR-1
21st Feb 20237:00 amRNSAMSL Aero's all-electric aircraft maiden flight
10th Feb 20239:55 amRNSNotice of Results
31st Jan 202310:00 amRNSTotal Voting Rights
30th Jan 20237:00 amRNSStatement re press speculation
24th Jan 20231:18 pmRNSForm 8.3 - Mirriad Advertising plc
18th Jan 20237:00 amRNSDirectorate Change
11th Jan 20237:00 amRNSPortfolio company Oxbotica raises $140m Series C
3rd Jan 202311:48 amRNSTotal Voting Rights
12th Dec 20224:58 pmRNSAGM post-meeting shareholder engagement update
7th Dec 20224:39 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSIstesso announces FDA Fast Track for MBS2320
2nd Dec 202211:38 amRNSPortfolio company funding leads to £36m gain
30th Nov 202210:41 amRNSTotal Voting Rights
21st Nov 20222:13 pmRNSLife sciences presentation postponed
2nd Nov 20223:51 pmRNSInvestor presentation on life sciences
1st Nov 20228:59 amRNSNotification of major holdings
31st Oct 20224:35 pmRNSDirector/PDMR Shareholding
27th Oct 20224:55 pmRNSPDMR Dealing – SAYE Exercise
24th Oct 20226:02 pmRNSHolding(s) in Company
14th Oct 20229:42 amRNSHolding(s) in Company
30th Sep 202210:39 amRNSTotal Voting Rights
21st Sep 20225:29 pmRNSHolding(s) in Company
20th Sep 20226:10 pmRNSDirector/PDMR Shareholding
15th Sep 20224:41 pmRNSInvestor presentation
14th Sep 20224:33 pmRNSFurther re Scrip Dividend
13th Sep 20226:00 pmRNSFurther re Interim Scrip Dividend
13th Sep 20227:01 amEQSIP Group Trust (IPO): Initiation — International investor in impactful innovation
7th Sep 20224:33 pmRNSDirector/PDMR Shareholding, SAYE scheme
31st Aug 20228:51 amRNSIstesso starts Phase 2b trial of MBS2320
30th Aug 202212:59 pmRNSCash acquisition of portfolio company Diurnal
18th Aug 20229:25 amRNSScrip Dividend Reference Price
11th Aug 202210:50 amRNSHolding(s) in Company
3rd Aug 20227:00 amRNSHalf-yearly results
2nd Aug 20227:00 amRNSPortfolio company Hysata completes funding round
13th Jul 20229:30 amRNSNotice of Results
30th Jun 20225:46 pmRNSRSP awards and Scrip Elections
29th Jun 20229:16 amRNSFurther re Scrip Dividend
22nd Jun 20227:00 amRNSLaunches ‘Kiko Ventures’ cleantech platform
16th Jun 202211:27 amRNSDirector/PDMR Shareholding
14th Jun 20227:00 amRNSAGM Statement
8th Jun 20227:30 amRNSTR-1
6th Jun 20228:14 amRNSScrip Dividend Reference Price
1st Jun 20223:23 pmRNSInvestor presentation; AGM arrangements
13th May 202212:43 pmRNSDirector Declaration
9th May 20225:21 pmRNSNotice of AGM, Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.